We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for medical device manufacturers on when electronic instructions for use can be used.
Guidance on the main issues of wheelchairs in cars and private transport - reminders for safe use.
The New Active Substance Work Sharing Initiative (NASWSI) has successfully approved several medicines through this international collaboration and continues to foster cooperation and strong relationships between its Access p…
How investigators and sponsors should manage clinical trials during COVID-19
The process to convert Parallel Distribution Notices (PDNs) into Parallel Import Licences (PILs)
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Every year MHRA receives requests for its staff to speak at conferences and other events across the world.
E-learning modules for healthcare professionals on minimising the risks of using medicines and information on how to access medical device modules.
A major initiative to ensure pregnant and breastfeeding women can make informed decisions about their healthcare
This guidance has been produced in collaboration with the UK Kidney Patient Safety Committee (KPSC), to summarise known safety issues with dialysis and continuous renal replacement therapy (CRRT) and describe what to do to m…
A flyer to circulate to customers alongside a field safety notice covering what it is and why it's important to take action.
The way you apply to licence biological products has changed
Guidance on naming human medicines, including Braille requirements for the name on the product label.
Guidance for specialists for initiation of valproate in female patients and for annual review and pregnancy testing to support adherence to pregnancy prevention requirements during the pandemic.
Cancel a marketing authorisation, traditional herbal registration or parallel import product licence or withdraw a pending submission.
Guidance for healthcare professionals on using single-use medical devices.
This guideline is to provide developers of biosimilar products with a clear outline of the requirements in Great Britain.
Guidance for healthcare professionals on the use and management of blood pressure management devices.
How to get fast-track approval of medical devices during COVID-19.
How to comply with the regulatory requirements for manufacturing custom-made medical devices.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).